Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
66
IHE Quote, Financials, Valuation and Earnings
Last price:
$82.92
Seasonality move
:
2.21%
Day range:
$82.86 - $83.67
52-week range:
$58.97 - $86.17
Dividend yield:
1.35%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
70.9K
Avg. volume:
106.3K
1-year change:
20.29%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IAK
iShares US Insurance ETF
|
-- | -- | -- | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
$83.06 | -- | -- | -- | $0.31 | 1.35% | -- |
|
IAK
iShares US Insurance ETF
|
$132.78 | -- | -- | -- | $0.51 | 1.78% | -- |
|
IAT
iShares US Regional Banks ETF
|
$53.77 | -- | -- | -- | $0.40 | 2.68% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$48.59 | -- | -- | -- | $0.11 | 0.79% | -- |
|
IHI
iShares US Medical Devices ETF
|
$63.31 | -- | -- | -- | $0.06 | 0.41% | -- |
|
IYG
iShares US Financial Services ETF
|
$90.39 | -- | -- | -- | $0.23 | 1.01% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 0.266 | -- | -- |
|
IAK
iShares US Insurance ETF
|
-- | 0.235 | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | 1.676 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 0.644 | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | 0.868 | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | 1.175 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IAK
iShares US Insurance ETF
|
-- | -- | -- | -- | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | -- | -- | -- | -- | -- |
iShares US Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns IHE or IAK?
iShares US Insurance ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Insurance ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IAKiShares US Insurance ETF-- -- -- -
What do Analysts Say About IHE or IAK?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Insurance ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Insurance ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Insurance ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IAKiShares US Insurance ETF0 0 0 -
Is IHE or IAK More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Insurance ETF has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.647%.
-
Which is a Better Dividend Stock IHE or IAK?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.31 per share corresponding to a yield of 1.35%. iShares US Insurance ETF offers a yield of 1.78% to investors and pays a quarterly dividend of $0.51 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Insurance ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IAK?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Insurance ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Insurance ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Insurance ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Insurance ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IAKiShares US Insurance ETF-- -- -- --
-
Which has Higher Returns IHE or IAT?
iShares US Regional Banks ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Regional Banks ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IATiShares US Regional Banks ETF-- -- -- -
What do Analysts Say About IHE or IAT?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Regional Banks ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Regional Banks ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Regional Banks ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IATiShares US Regional Banks ETF0 0 0 -
Is IHE or IAT More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Regional Banks ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.983%.
-
Which is a Better Dividend Stock IHE or IAT?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.31 per share corresponding to a yield of 1.35%. iShares US Regional Banks ETF offers a yield of 2.68% to investors and pays a quarterly dividend of $0.40 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Regional Banks ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IAT?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Regional Banks ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Regional Banks ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Regional Banks ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Regional Banks ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IATiShares US Regional Banks ETF-- -- -- --
-
Which has Higher Returns IHE or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About IHE or IHF?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is IHE or IHF More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.731, suggesting its less volatile than the S&P 500 by 26.927%.
-
Which is a Better Dividend Stock IHE or IHF?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.31 per share corresponding to a yield of 1.35%. iShares US Healthcare Providers ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $0.11 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IHF?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns IHE or IHI?
iShares US Medical Devices ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IHIiShares US Medical Devices ETF-- -- -- -
What do Analysts Say About IHE or IHI?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Medical Devices ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Medical Devices ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IHIiShares US Medical Devices ETF0 0 0 -
Is IHE or IHI More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 1.010, suggesting its more volatile than the S&P 500 by 1.009%.
-
Which is a Better Dividend Stock IHE or IHI?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.31 per share corresponding to a yield of 1.35%. iShares US Medical Devices ETF offers a yield of 0.41% to investors and pays a quarterly dividend of $0.06 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IHI?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IHIiShares US Medical Devices ETF-- -- -- --
-
Which has Higher Returns IHE or IYG?
iShares US Financial Services ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Financial Services ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IYGiShares US Financial Services ETF-- -- -- -
What do Analysts Say About IHE or IYG?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Financial Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Financial Services ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Financial Services ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IYGiShares US Financial Services ETF0 0 0 -
Is IHE or IYG More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Financial Services ETF has a beta of 1.143, suggesting its more volatile than the S&P 500 by 14.331%.
-
Which is a Better Dividend Stock IHE or IYG?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.31 per share corresponding to a yield of 1.35%. iShares US Financial Services ETF offers a yield of 1.01% to investors and pays a quarterly dividend of $0.23 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Financial Services ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IYG?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Financial Services ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Financial Services ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Financial Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Financial Services ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IYGiShares US Financial Services ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
